Ocuphire Pharma Investor Day Presentation Deck slide image

Ocuphire Pharma Investor Day Presentation Deck

P 78 0.4% Ocuphire PHARMA Nyxol with LDP as Adjunctive Therapy in Presbyopia Presented by: Jay Pepose, MD, PhD
View entire presentation